Search Results - "Dyras, P"

Immunological effects of recombinant human erythropoietin on end-stage renal disease pediatric and adult patients by Salvati, F, Liani, M, La Torre, M, Golato, M, Di Sciascio, N, Pietrzyk, J, Dyras, P

Get more information

Growth hormone therapy and lipid profile in children on chronic peritoneal dialysis by JEDRZEJOWSKI, Antoni, PANCZYK-TOMASZEWSKA, Małgorzata, ROSZKOWSKA-BLAIM, Maria, LIS, Danuta, GAŁAZKA, Barbara, DYRAS, Pawel

“…The aim of the study was to assess the effect of recombinant human growth hormone (rhGH) on serum lipids in children treated with chronic peritoneal dialysis…”
Get full text

Clinical and metabolic effects of erythropoietin administration in hemodialyzed children by Dyras, P, Pietrzyk, J A, Sancewicz-Pach, K, Lenik, J

“…The study aimed at the evaluation of metabolic effect of recombinant human erythropoietin (EPO) in children treated with repeated hemodialyses. The research…”
Get more information

Results of treatment with recombinant human growth hormone in children with growth retardation in end-stage renal disease by Sieniawska, M, Pańczyk-Tomaszewska, M, Ziółkowska, H, Jedrzejowski, A, Leszczyńska, B, Dyras, P, Kałuzyńska, A, Makulska, I, Pietrzyk, J A, Rubik, J, Siteń, G, Stachowski, J, Szprynger, K, Zurowska, A, Roszkowska-Blaim, M

“…The aim of the study was to estimate the results of recombinant human growth hormone (rhGH) treatment in children with end-stage renal disease (ESRD). 60…”
Get more information

Effect of using recombinant human erythropoietin on the effectiveness of hemodialysis in children with terminal renal failure by Pietrzyk, J A, Dyras, P, Smolnik, T, Szymowska, M

“…Recombinant human erythropoietin (EPO) was administered to 12 children aged 8-17 years subjected to hemodialysis for a mean period of 16 (S.D. 19.7) months…”
Get more information

Effect of recombinant human erythropoietin--rHu-EPO on the metabolism of children treated by long-term hemodialysis by Pietrzyk, J A, Smolnik, T, Szymowska, M, Dyras, P, Lenik, J

“…Recombinant human erythropoietin (EPO) was administered to 12 children with terminal renal failure aged 8-17 years subjected to hemodialysis for a mean period…”
Get more information

Dialysis adequacy and nutrition by Pietrzyk, J A, Sułowicz, W, Dyras, P, Spodaryk, M

Get more information

Time-optimal control of hemodialysis by Ziolko, Pietrzyk, Dyras

“…A set of three first-order differential equations makes up a three-compartment model enabling the control of high-efficiency short lasting hemodialysis. The…”
Get full text